CoChat

Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Abstract

Aims/hypotheses Current evidence indicates that statins increase the risk of incident diabetes; however, the relationship between statins and glycaemic control in people with established diabetes has not been well characterised. To address this question, we conducted a meta-analysis of randomised controlled trials (RCTs) of statins in patients with diabetes for whom there was available data on glycaemic control.Methods We identified studies published between January 1970 and November 2013 by searching electronic databases and reference lists. We included RCTs in which the intervention group received statins and the control group received placebo or standard treatment, with >200 participants enrolled, with the intervention lasting >12 weeks and with pre- and post-intervention HbA1c reported. We combined study-specific estimates using random-effects model meta-analysis.Results In a pooled analysis of nine trials involving 9,696 participants (4,980 statin, 4,716 control) and an average follow-up of 3.6 years, the mean HbA1c of participants randomised to statins was higher than those randomised to the control group: mean difference (95% CI) was 0.12% (0.04, 0.20) or 1.3 mmol/mol (0.4, 2.2); p = 0.003. There was moderate heterogeneity across the studies (I (2) = 54%, p = 0.014) not explained by available study-level characteristics. This review was limited by the small number of studies, available data on only three statins and sparse reporting on changes in use of glucose-lowering medications.Conclusions/interpretation Statin treatment is associated with a modest increase in HbA1c in patients with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3374-x

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 137

Metadata

Authors
Erqou, S., Lee, C. C., & Adler, A. I.
Affiliations
  • Weill Cornell Medicine (US)
  • University of Toronto (CA)
  • Addenbrooke's Hospital (GB)
Corresponding author
Erqou, Sebhat
Venue
Diabetologia
Published
2014-09-23
Volume
57
Issue
12
Pages
2444-2452
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2140272923
Cited by
126
References
45
Citations by year
2026: 5 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 8 · 2020: 10 · 2019: 14 · 2018: 10 · 2017: 9 · 2016: 14 · 2015: 13 · 2014: 2
FWCI
2.39
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
Weill Cornell Medical College
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
statins, diabetes mellitus, glycemic control, HbA1c, hyperglycemia, glucose-lowering medications, lipid-lowering therapy
MeSH terms
Blood Glucose, Diabetes Mellitus, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s00125-014-3374-x
The paper
Erqou, S., Lee, C. C., & Adler, A. I. (2014). Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia. https://doi.org/10.1007/s00125-014-3374-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.